Immediate Amelioration of Severe Respiratory Distress in Sjögren's Syndrome with COVID-19 Treated with a Single Dose of Off-label Tocilizumab - Kataoka, Hiroshi; Kodama, Fumihiro; Tomita, Tomoko; Kondo, Makoto; Nagasaka, Atsushi; Nishikawa, Shuji; Mukai, Masaya (Internal Medicine, 2021)
Keywords: acute respiratory distress syndrome; Adrenal Cortex Hormones - therapeutic use; Aged, 80 and over; Anti-Inflammatory Agents - therapeutic use; Antibodies, Monoclonal, Humanized - therapeutic use; Autoimmune diseases; Case Report; Coronaviruses; COVID-19; COVID-19 - complications; COVID-19 - immunology; Cytokine Release Syndrome; cytokine storm; Diabetes mellitus; Drug Therapy, Combination; Dyspnea - etiology; Humans; Internal medicine; Male; Off-Label Use; Pandemics; Public health; Respiratory Distress Syndrome - drug therapy; Respiratory Distress Syndrome - etiology; Respiratory Insufficiency - drug therapy; Risk factors; SARS-CoV-2; Sjogren's syndrome; Sjogren's Syndrome - complications; Sjögren's syndrome; Supplements; tocilizumab; COVID-19; acute respiratory distress syndrome; tocilizumab; cytokine storm; Sjögren's syndrome